| Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final … E Díaz-Rubio, J Tabernero, A Gómez-España, B Massutí, J Sastre, ... Journal of Clinical Oncology 25 (27), 4224-4230, 2007 | 356 | 2007 |
| Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM R Vera, E González-Flores, C Rubio, J Urbano, M Valero Camps, ... Clinical and Translational Oncology 22, 647-662, 2020 | 76 | 2020 |
| SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018) MA Gómez-España, J Gallego, E González-Flores, J Maurel, D Páez, ... Clinical and Translational Oncology 21, 46-54, 2019 | 68 | 2019 |
| Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations … J Sastre, E Aranda, B Massutí, J Tabernero, M Chaves, A Abad, A Carrato, ... Critical reviews in oncology/hematology 70 (2), 134-144, 2009 | 64 | 2009 |
| Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer A Martín-Blázquez, C Díaz, E González-Flores, D Franco-Rivas, ... Scientific Reports 9 (1), 20198, 2019 | 49 | 2019 |
| Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX JF Emile, C Julié, K Le Malicot, C Lepage, J Tabernero, E Mini, ... European journal of cancer 82, 16-24, 2017 | 44 | 2017 |
| FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and≥ 3 circulating tumour cells: the randomised phase III VISNÚ-1 trial E Aranda, JM Viéitez, A Gómez-España, SG Calle, A Salud-Salvia, ... ESMO open 5 (6), e000944, 2020 | 43 | 2020 |
| Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II … P Garcia-Alfonso, A Munoz-Martin, M Mendez-Urena, R Quiben-Pereira, ... British journal of cancer 101 (7), 1039-1043, 2009 | 40 | 2009 |
| A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer JL Bayo-Calero, JI Mayordomo, P Sánchez-Rovira, R Pérez-Carrión, ... Clinical breast cancer 8 (3), 264-268, 2008 | 34 | 2008 |
| Recommendations for follow-up of colorectal cancer survivors R Vera, J Aparicio, F Carballo, M Esteva, E González-Flores, J Santianes, ... Clinical and Translational Oncology 21, 1302-1311, 2019 | 32 | 2019 |
| General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force’s position statement R Gironés Sarrió, M Antonio Rebollo, MJ Molina Garrido, C Guillén-Ponce, ... Clinical and Translational Oncology 20, 1246-1251, 2018 | 32 | 2018 |
| SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs)(2018) E González-Flores, R Serrano, I Sevilla, A Viúdez, J Barriuso, M Benavent, ... Clinical and Translational Oncology 21, 55-63, 2019 | 28 | 2019 |
| Randomized phase III study comparing FOLFOX+ bevacizumab versus folfoxiri+ bevacizumab (BEV) as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with≥ 3 … J Sastre, JM Vieitez, MA Gomez-España, S Gil Calle, A Salud Salvia, ... Journal of Clinical Oncology 37 (15_suppl), 3507-3507, 2019 | 25 | 2019 |
| SEOM Clinical Guideline of localized rectal cancer (2016) E González-Flores, F Losa, C Pericay, E Polo, S Roselló, MJ Safont, ... Clinical and Translational Oncology 18, 1163-1171, 2016 | 24 | 2016 |
| Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish … M Benavides, C Pericay, M Valladares-Ayerbes, S Gil-Calle, B Massutí, ... Clinical Colorectal Cancer 11 (3), 200-206, 2012 | 24 | 2012 |
| SEOM clinical guidelines for the adjuvant treatment of colorectal cancer C Grávalos Castro, J Maurel Santasusana, F Rivera Herrero, ... Clinical and Translational Oncology 12, 724-728, 2010 | 21 | 2010 |
| SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013 J Maurel, C Grávalos, F Rivera, R Vera, E González Flores Clinical and Translational Oncology 15, 991-995, 2013 | 19 | 2013 |
| Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study P Garcia-Alfonso, M Chaves, A Muñoz, A Salud, M García-Gonzalez, ... BMC cancer 15, 1-9, 2015 | 18 | 2015 |
| Geriatric oncology in Spain: survey results and analysis of the current situation R Gironés, I Morilla, C Guillen-Ponce, MD Torregrosa, I Paredero, ... Clinical and Translational Oncology 20, 1087-1092, 2018 | 14 | 2018 |
| SEOM clinical guidelines for the treatment of advanced colorectal cancer R García-Carbonero, MA Gómez España, E Casado Sáenz, ... Clinical and Translational Oncology 12, 729-734, 2010 | 14 | 2010 |
